Selling And Administration Expenses Değişiklik Tarih
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Amgen USD 1.69B 191M 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
Bayer EUR 3.71B 628M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Cytokinetics USD 57.37M 4.97M 2025-03
Eisai JPY 106.51B 1.99B 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Exelixis USD 134.86M 2.32M 2025-07
Genmab DKK 126M 1.12B 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Incyte USD 331.02M 5.33M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.63B 104M 2025-06
Moderna USD 230M 18M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06
Pfizer USD 3.01B 1.27B 2025-03
Sanofi EUR 1.24B 1.44B 2024-12
Takeda JPY 255.89B 39.98B 2025-06
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
Xencor USD 17.34M 2.42M 2025-03


Exelixis Satış Ve Yönetim Giderleri - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Aug 2025.